Correlation of HbA1c levels in late pregnancy with maternal and perinatal outcome in patients with gestational diabetes mellitus


  • Navjot Kaur Department of Obstetrics and Gynaecology, Government Medical College and Hospital, Chandigarh, India
  • Poonam Goel Department of Obstetrics and Gynaecology, Government Medical College and Hospital, Chandigarh, India
  • Reeti Mehra Department of Obstetrics and Gynaecology, Government Medical College and Hospital, Chandigarh, India
  • Jasbinder Kaur Department of Biochemistry, Government Medical College and Hospital, Chandigarh, India



Gestational diabetes mellitus, HbA1c, Late trimester, LGA babies, Polyhydramnios


Background: Estimation of HbA1c in gestational diabetes mellitus patients is not being recommended by any societies/guidelines as studies regarding the role of HbA1c for monitoring of euglycemic control and predicting the maternal and perinatal outcomes in GDM patients (unlike overt diabetes) are conflicting and sparse.

Methods: This was a prospective study with an aim to evaluate the role of HbA1c estimation in late pregnancy (early and late third trimester) for prediction of pregnancy outcomes in GDM patients. 53 patients with GDM (diagnosed before third trimester) were recruited for the study. HbA1c levels were estimated in late pregnancy (at 28-32 weeks and again repeated at 37 - 39 weeks or at the time of delivery). Correlation of HbA1c levels in third trimester with maternal and perinatal outcome was studied in patients with gestational diabetes mellitus and cut off taken was 5.8%.

Results: Of the total 53 patients 54.7% had HbA1c levels <5.8% and 45.3% had HbA1c ≥5.8% done at 28-32 weeks. Also when HbA1c levels done at 37-39 weeks POG/ at the time of delivery, 52.8% patients had <5.8% and 47.2% had HbA1c ≥5.8%. Approximately one-fourth of the patients had HbA1c ≥ 5.8% even with normal blood sugar levels (euglycemic) control. There was statistically significant increased incidence of polyhydramnios, LGA (large for gestational age babies) and increased mean birth weight in patients with HbA1c ≥ 5.8%, done in late pregnancy. However there was no statistically significant difference in the incidence of preterm labour, gestational hypertension or preeclampsia, urinary tract infections, vulvovaginal infections, caesarean deliveries and postpartum haemorrhage in patients with HbA1c ≥5.8% compared to patients with HbA1c <5.8%.

Conclusions: The study revealed that in patients of GDM with HbA1c levels ≥5.8% done in third trimester was statistically significantly associated with increased incidence of polyhydramnios, large for gestational age babies and increased mean birth weight when compared to patients with HbA1c <5.8%.


World Health Organisation Guideline. Diagnostic Criteria and Classification of Hyperglycaemia First Detected in Pregnancy. Geneva, World Health Org. 2013 WHO/NMH/MND/13.2.

International Diabetes Federation. IDF Diabetes Atlas, 8th edn. Brussels, Belgium; International Diabetes Federation; 2017. Available at http;// diabetes-atlas/134-idf-diabetes-atlas-8th-edition.html

Peters RK, Kjos SL, Xiang A, Buchanan TA. Long-term diabetogenic effect of single pregnancy in women with previous gestational diabetes mellitus. Lancet Lond Engl. 1996;347:227-30.

Mills JL. Malformations in infants of diabetic mothers. Teratology. 1982;25:385-94.

Yogev Y, Xenakis EMJ, Langer O. The association between preeclampsia and the severity of gestational diabetes: the impact of glycemic control. Am J Obstet Gynecol. 2004;191:1655-60.

Ehrenberg HM, Durnwald CP, Catalano P, Mercer BM. The influence of obesity and diabetes on the risk of cesarean delivery. Am J Obstet Gynecol. 2004;191:969-74.

Mcfarland KF, Murtiashaw M, Baynes JW. Clinical value of glycosylated serum protein and glycosylated hemoglobin levels in the diagnosis of gestational diabetes mellitus. Obstet Gynecol. 1984;64:516-8.

Cousins L, Dattel BJ, Hollingsworth DR, Zettner A. Glycosylated hemoglobin as a screening test for carbohydrate intolerance in pregnancy. Am J Obstet Gynecol. 1984;150:455-60.

International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33:676-82.

Odsæter IH, Åsberg A, Vanky E, Carlsen SM. HbA1c as screening for gestational diabetes mellitus in women with polycystic ovary syndrome. BMC Endocr Disord. 2015;15:38.

Garner LA, Miller E, Katon J. First-trimester A1C as a tool to predict the development of gestational diabetes in high-risk women. Obstet Gynecol. 2014;123:52.

Lowe LP, Metzger BE, Dyer AR, Lowe J, McCance DR, Lappin TRJ. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations of maternal A1C and glucose with pregnancy outcomes. Diabetes Care. 2012;35:574-80.

Yu H, Qi X, Wang X. Application of glycated hemoglobin in the perinatal period. Int J Clin Exp Med. 2014;7:4653-9.

Kwon SS, Kwon JY, Park YW, Kim YH, Lim JB. HbA1c for diagnosis and prognosis of gestational diabetes mellitus. Diabetes Res Clin Pract. 2015;110:38-43.

National Collaborating Centre for Women's and Children’s Health (commissioned by the National Institute for Health and Clinical Excellence). Diabetes in Pregnancy: Management of diabetes and its complications from preconception to the postnatal period. NICE Clinical Guideline 63: 2008. Available at www. nice. org. uk/ nicemedia /pdf /CG063 Guidance. Pdf

Sengupta R, Jesmen S, Banu LA, Habib SH. HbA1C level in 2nd and 3rd trimester with pregnancy outcome in diabetic patients. Birdem Med J. 2012;2:23-8.

Subhash S, Sathyamoorthy M, Prasanna R, Karthikeyan P, Sekar P, Reddy R. HbA1c level in last trimester pregnancy in predicting macrosomia and hypoglycemia in neonate. Int J Contemp Pediatr. 2016;5:1334-8.

Arumugam K, Abdul MN. Glycated haemoglobin is a good predictor of neonatal hypoglycaemia in pregnancies complicated by diabetes. Malaysian J Pathology. 2011;33:21-4.

Barquiel B, Herranz L, Hillman N, Burgos MÁ, Grande C, Tukia KM. HbA1c and gestational weight gain are factors that influence neonatal outcome in mothers with gestational diabetes. J Womens Health. 2016;25:579-85.

Jiwani A, Marseille E, Lohse N, Damm P, Hod M, Kahn JG. Gestational diabetes mellitus: results from a survey of country prevalence and practices. Int Soc Perinat Obstet. 2012;25:600-710.

Versantvoort ARE, Roosmalen J, Radder JK. Course of HbA1c in non-diabetic pregnancy related to birth weight. Neth J Med. 2013;71:22-5.

Radder JK, Roosmalen J. HbA1c in healthy, pregnant women. Neth J Med. 2005;63:256-9.

Ho YR, Wang P, Lu MC, Tseng ST, Yang CP, Yan YH. Associations of mid-pregnancy HbA1c with gestational diabetes and risk of adverse pregnancy outcomes in high-risk Taiwanese women. Plos One. 2017;15:1-12.

Khairy TH, Mohamed EM, Hussain SH, Alefaie MS. Value of glycosylated hemoglobin at 34 weeks gestation in the prediction of adverse neonatal outcome. Egypt J Hosp Med. 2017;69:1880-8.






Original Research Articles